tamsulosin has been researched along with Impotence in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 9 (21.95) | 29.6817 |
| 2010's | 21 (51.22) | 24.3611 |
| 2020's | 9 (21.95) | 2.80 |
| Authors | Studies |
|---|---|
| Kazikhinurov, AA; Kazikhinurov, RA; Kazikhinurova, KA; Pavlov, VN; Sabirzyanov, SS; Saleeva, YD | 1 |
| Akamatsu, S; Goto, T; Kobayashi, T; Matsubara, K; Matsui, Y; Negoro, H; Ogawa, O; Omura, T; Terada, N; Yamamoto, T; Yonezawa, A | 1 |
| Chapple, C; De Nunzio, C; Frizzi, J; Gacci, M; Gravas, S; Kaplan, SA; Maggi, M; McVary, KT; Saleh, O; Sebastianelli, A; Serni, S; Spatafora, P; Tubaro, A; Vignozzi, L | 1 |
| Rezk, MR; Tantawy, MA; Wadie, M; Weshahy, SA | 1 |
| Ahn, ST; Jeong, HG; Kim, JW; Lee, DH; Moon, DG; Oh, MM; Park, HS | 1 |
| Huang, H; Huang, WP; Ye, XT; Zhang, FY | 1 |
| Cai, Z; Li, H; Ma, C; Xiong, J; Zhang, J | 1 |
| Chapple, C; Gacci, M; Gravas, S; Kaplan, S; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L | 1 |
| Chapple, C; Gacci, M; Gemma, L; Gravas, S; Kaplan, SA; Liaci, A; Maggi, M; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L; Zaccaro, C | 1 |
| Aron, M; Berger, AK; Berger, M; Desai, M; Knijnik, PG; Paludo, AO; Silva Neto, B | 1 |
| Ahn, TY; Hyun, JS; Jung, J; Kim, SW; Lee, SW; Min, KS; Moon, DG; Moon, KH; Park, JK; Park, K; Park, NC; Ryu, JK; Son, H; Yang, DY; Yang, SK | 1 |
| Giuliano, F; Karanastasis, D; Manyak, MJ; Palacios-Moreno, JM; Plastino, J; Roehrborn, CG; Roos, EPM; Rosen, RC; Santos, JC; Wilson, TH | 1 |
| Kaplan, SA | 2 |
| Dai, Y; Jiann, BP; Li, H; Li, P; Lou, Y; Park, HJ; Viktrup, L; Ye, Z; Zhang, X; Zhang, Z | 1 |
| Kitta, T | 1 |
| Cai, T; Cui, Y; Ding, R; Gao, Z; Wu, J; Zhou, Z | 1 |
| Cho, JY; Jang, IJ; Kim, BH; Kim, JR; Kim, MG; Lim, KS; Shin, SG; Yu, KS | 1 |
| Cantoro, U; Catanzariti, F; Lacetera, V; Muzzonigro, G; Polito, M; Quaresima, L | 1 |
| Mandal, AK; Mete, UK; Singh, DV; Singh, SK | 1 |
| Chen, L; Feng, YG; Zhou, ZH | 1 |
| Hyun, JS; Kim, SW; Ko, K; Lee, SW; Lee, WK; Moon, du G; Moon, KH; Park, JK; Park, K; Park, NC; Son, HC; Yang, DY | 1 |
| Altay, AB; Apaydin, E; Bademkiran, F; Cikili, N; Semerci, MB; Turna, B; Umul, M | 1 |
| Doros, G; Haider, A; Haider, KS; Traish, AM | 1 |
| Fallah-Karkan, M; Hassanzadeh-Hadad, A; Karami, H | 1 |
| Andersson, KE | 1 |
| Bechara, A; Casabé, A; Dedola, P; Haime, S; Hernández, C; Rey, H; Romano, S | 1 |
| Aslan, Y; Atan, A; Aydin, O; Ener, K; Nalcacioglu, V; Tuncel, A | 1 |
| Fujii, T; Fukumoto, K; Hara, R; Jo, Y; Miyaji, Y; Nagai, A; Sone, A; Yokoyama, T | 1 |
| Cox, D; Giuliano, F; Mirone, V; Oelke, M; Viktrup, L; Xu, L | 1 |
| Carini, M; Gacci, M; Lapini, A; Maggi, M; Rossetti, MA; Serni, S; Siena, G; Tosi, N; Vignozzi, L; Vittori, G | 1 |
| Cox, D; Giuliano, F; Hatzimouratidis, K; Jungwirth, A; Oelke, M; Viktrup, L; Watts, S | 1 |
| Schulman, CC | 1 |
| Michel, MC | 1 |
| Wyllie, MG | 1 |
| de la Rosette, JJ; Michel, MC; van Dijk, MM | 1 |
| O'Leary, MP | 1 |
| Barqawi, AB; Crawford, ED; Myers, JB; O'Donnell, C | 1 |
| Claes, H; De Reijke, TM; Folkestad, B; Höfner, K; Speakman, MJ | 1 |
| Kim, SC; Lee, MY; Lee, SK; Seo, KK; Song, ES | 1 |
8 review(s) available for tamsulosin and Impotence
| Article | Year |
|---|---|
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis.
Topics: Bayes Theorem; Databases, Factual; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Safety; Sildenafil Citrate; Tadalafil; Tamsulosin; Treatment Outcome | 2020 |
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.
Topics: Combined Modality Therapy; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Dutasteride; Erectile Dysfunction; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tamsulosin; Treatment Outcome | 2019 |
Dutasteride (Avodart) with tamsulosin (Flomax) for benign prostatic hyperplasia.
Topics: Azasteroids; Clinical Trials as Topic; Drug Therapy, Combination; Dutasteride; Erectile Dysfunction; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2008 |
Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Blood Pressure; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Male; Phytotherapy; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2003 |
One drug fits all.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Combinations; Drug Industry; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2005 |
Effects of alpha(1)-adrenoceptor antagonists on male sexual function.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Aged; Doxazosin; Ejaculation; Erectile Dysfunction; Humans; Libido; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin | 2006 |
Treatment and pharmacologic management of BPH in the context of common comorbidities.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome | 2006 |
17 trial(s) available for tamsulosin and Impotence
| Article | Year |
|---|---|
Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study.
Topics: Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
[Therapeutic effect of tadalafil on lower urinary tract symptoms with erectile dysfunction].
Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome | 2019 |
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Topics: Aged; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2017 |
A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Topics: Aged; Aged, 80 and over; Dutasteride; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Penile Erection; Placebos; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled s
Topics: Aged; China; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostatic Hyperplasia; Republic of Korea; Severity of Illness Index; Tadalafil; Taiwan; Tamsulosin; Treatment Outcome | 2019 |
The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Double-Blind Method; Drug Interactions; Erectile Dysfunction; Healthy Volunteers; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostatic Hyperplasia; Pyrimidines; Sulfonamides; Tamsulosin; Young Adult | 2013 |
A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Retention | 2014 |
[Clinical efficacy of Shuganyiyang capsule combined with Western medicine for the treatment of type III prostatitis complicated by erectile dysfunction].
Topics: Capsules; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Phytotherapy; Prostatitis; Sulfonamides; Tamsulosin; Treatment Outcome | 2013 |
Effect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin.
Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Quality of Life; Quinuclidines; Rheology; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urological Agents | 2014 |
Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tadalafil; Tamsulosin | 2016 |
Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.
Topics: Aged; Carbolines; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Retention | 2008 |
Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Prostatism; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Tamsulosin | 2010 |
Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Ejaculation; Erectile Dysfunction; Humans; Indoles; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination; Urination Disorders | 2011 |
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Vasodilator Agents | 2012 |
A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Triazines; Vardenafil Dihydrochloride | 2012 |
Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Analysis of Variance; Carbolines; Double-Blind Method; Drug Administration Schedule; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Orgasm; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tadalafil; Tamsulosin | 2013 |
Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Incidence; Libido; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome; Urethral Obstruction | 1999 |
16 other study(ies) available for tamsulosin and Impotence
| Article | Year |
|---|---|
[The use of prostate extract preparations in patients after transurethral resection of prostate for its benign hyperplasia].
Topics: Erectile Dysfunction; Humans; Hyperplasia; Male; Prostate; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome | 2022 |
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Urological Agents | 2021 |
Smart spectrophotometric assessment of tamsulosin hydrochloride and tadalafil in their new pharmaceutical formulation for treatment of benign prostatic hyperplasia and erectile dysfunction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Capsules; Drug Combinations; Drug Compounding; Erectile Dysfunction; Humans; Limit of Detection; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Spectrophotometry; Tadalafil; Tamsulosin | 2020 |
Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction.
Topics: Age Factors; Aged; Drug Combinations; Erectile Dysfunction; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Tadalafil; Tamsulosin; Treatment Failure; Urological Agents | 2020 |
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin | 2021 |
Initial experience with first postoperative day Foley catheter removal after robot-assisted radical prostatectomy.
Topics: Device Removal; Enhanced Recovery After Surgery; Erectile Dysfunction; Humans; Male; Middle Aged; Postoperative Care; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Robotic Surgical Procedures; Tamsulosin; Time Factors; Urinary Catheters; Urinary Incontinence; Urinary Retention; Urological Agents | 2021 |
Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin | 2018 |
Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and ta
Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin | 2019 |
Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chronic Disease; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Prostatitis; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Tamsulosin; Young Adult | 2013 |
The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Autonomic Nervous System; Blood Glucose; Body Mass Index; Erectile Dysfunction; Humans; Lipids; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Testosterone | 2014 |
Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia.
Topics: Aged; Cohort Studies; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Testosterone; Urological Agents | 2015 |
Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia.
Topics: Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia; Tamsulosin; Testosterone | 2017 |
How many drugs for LUTS due to BPH are too many?
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Imidazoles; Male; Muscarinic Antagonists; Phenylpropanolamine; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Tolterodine Tartrate; Triazines; Urination Disorders; Vardenafil Dihydrochloride | 2008 |
Ejaculatory dysfunction and alpha-adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Ejaculation; Erectile Dysfunction; Humans; Male; Quinazolines; Sulfonamides; Tamsulosin | 2004 |
The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Sectional Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Quality of Life; Regression Analysis; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome | 2007 |
Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Animals; Blood Pressure; Dogs; Drug Synergism; Erectile Dysfunction; Humans; In Vitro Techniques; Injections; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth; Papaverine; Penile Erection; Phentolamine; Rabbits; Sulfonamides; Tamsulosin; Vasoactive Intestinal Peptide | 1999 |